NEOGENOMICS INC — Director's Dealing 2011

May 2, 2011

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NEOGENOMICS INC (NGNM)
CIK: 0001077183
Period of Report: 2011-05-02

Reporting Person: JONES STEVEN C (Director, Executive VP of Finance, 10% Owner)
Reporting Person: ASPEN SELECT HEALTHCARE LP (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	403804	Direct
Common Stock	8038123	Indirect
Common Stock	129412	Indirect
Common Stock	90000	Indirect
Common Stock	50476	Indirect
Common Stock	32157	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrant (right to buy)	$1.50	2012-06-07	6/7/2012 (350000)		Direct
Warrant (right to buy)	$1.50	2017-05-03	Common Stock (450000)		Direct
Warrant (right to buy)	$0.75	2014-02-09	Common Stock (83333)		Indirect

Footnotes

F1: Aspen Select Healthcare, LP is a private investment fund. Medical Venture Partners, LLC is the sole general partner of Aspen
Select Healthcare, LP, and Mr. Jones is a Managing Member of Medical Venture Partners, LLC. Mr. Jones disclaims beneficial
ownership of such shares except to the extent of his respective pecuniary interests therein.

F2: An investment partnership entity controlled by Steven Jones and Peter Peterson.. Mr. Jones disclaims beneficial ownership
of such shares except to the extent of his respective pecuniary interests therein.

F3: Such warrants were issued in connection with a consulting agreement, dated 5/3/2010. 225,000 of such warrants were vested as
of the date of the agreement for prior service. 112,500 of such warrants are subject to pro rata monthly vesting over a 24
month period beginning in May 2010 and ending in April 2012. 112,500 of such warrants are subject to performance vesting
based on whether NeoGenomics meets certain financial performance goals over a two year vesting period.